254 related articles for article (PubMed ID: 21546737)
1. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].
Ahr A; Scharl A; Göhring UJ; Crombach G; Stoffl M
Pathologe; 1995 Jul; 16(4):278-84. PubMed ID: 7667210
[TBL] [Abstract][Full Text] [Related]
4. [PS2 as a prognostic factor in 1065 cases of human breast cancer. A multicenter study].
Besse G; Kwiatkowski F; Gaillard G; Daver A; Dalifard I; Basuyau JP; Brunelle P; Wafflart J; Angibeau RM; Auvray E
Bull Cancer; 1994 Apr; 81(4):289-96. PubMed ID: 7703545
[TBL] [Abstract][Full Text] [Related]
5. Correlations of bcl-2 expression with clinicopathological features in breast cancer.
Lee HD; Koo JY; Jung WH
Yonsei Med J; 1997 Aug; 38(4):206-11. PubMed ID: 9339128
[TBL] [Abstract][Full Text] [Related]
6. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
Speiser P; Sliutz G; Zeillinger R; Czerwenka K; Jakesz R; Knogler W; Kury F; Reiner A; Sevelda P; Schneeberger C
Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):355-9. PubMed ID: 1634099
[TBL] [Abstract][Full Text] [Related]
7. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
[TBL] [Abstract][Full Text] [Related]
8. A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer.
Kohail HM; Elias EG; el-Nowiem SA; Bashirelahi N; Didolkar MS; Reed WP
Ann Surg; 1985 May; 201(5):611-7. PubMed ID: 2986565
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
Nagai MA; Marques LA; Yamamoto L; Fujiyama CT; Brentani MM
Int J Cancer; 1994 Nov; 59(3):351-6. PubMed ID: 7927940
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
Kommoss F; Pfisterer J; Idris T; Giese E; Sauerbrei W; Schäfer W; Thome M; Pfleiderer A
Anal Quant Cytol Histol; 1994 Jun; 16(3):203-10. PubMed ID: 7916848
[TBL] [Abstract][Full Text] [Related]
12. Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer.
Ioakim-Liossi A; Karakitsos P; Markopoulos C; Aroni K; Delivelioti K; Gogas J; Kyrkou K
Acta Cytol; 1997; 41(3):713-6. PubMed ID: 9167689
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 expression and DNA fragmentation in breast carcinoma, pathologic and steroid hormone receptors correlates.
Diaz-Cano SJ; Garcia-Moliner M; Carney W; Wolfe HJ
Diagn Mol Pathol; 1997 Aug; 6(4):199-208. PubMed ID: 9360841
[TBL] [Abstract][Full Text] [Related]
14. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy.
Giani C; Fierabracci P; Bonacci R; Gigliotti A; Campani D; De Negri F; Cecchetti D; Martino E; Pinchera A
J Clin Endocrinol Metab; 1996 Mar; 81(3):990-4. PubMed ID: 8772562
[TBL] [Abstract][Full Text] [Related]
15. Distribution of estrogen and progesterone receptors on primary tumor and lymph nodes in individual patients with breast cancer.
Klinga K; Kaufmann M; Runnebaum B; Kubli F
Oncology; 1982; 39(6):337-9. PubMed ID: 7133597
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status.
Collett K; Hartveit F; Skjaerven R; Maehle BO
J Clin Pathol; 1996 Nov; 49(11):920-5. PubMed ID: 8944613
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.
Klijn JG; Berns PM; Schmitz PI; Foekens JA
Endocr Rev; 1992 Feb; 13(1):3-17. PubMed ID: 1313356
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis.
Molino A; Turazza M; Bonetti A; Biondani P; Griso C; Adami L; Corgnati A; Nortilli R; Pollini GP; Modena S
Oncology; 1992; 49(2):82-8. PubMed ID: 1574256
[TBL] [Abstract][Full Text] [Related]
20. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.
Brentani MM; Franco EL; Oshima CT; Pacheco MM
Int J Cancer; 1986 Nov; 38(5):637-42. PubMed ID: 3770993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
